ProfileGDS5678 / 1453088_at
TitleAnti-VEGF and Anti-Notch treatment effect on U87 glioblastoma xenograft tumors [Mouse430_2]
OrganismMus musculus


control bevacizumab dibenzazepine GSM967852 GSM967853 GSM967854 GSM967855 GSM967856 GSM967862 GSM967863 GSM967864 GSM967865 GSM967857 GSM967858 GSM967859 GSM967860 GSM967861 12% 11% 12% 11% 13% 18% 11% 11% 12% 13% 12% 12% 11% 12% sort by agent Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM967852U87-EV human glioblastoma xenograft - Control 12.311312
GSM967853U87-EV human glioblastoma xenograft - Control 22.281311
GSM967854U87-EV human glioblastoma xenograft - Control 32.2923612
GSM967855U87-EV human glioblastoma xenograft - Control 42.2345811
GSM967856U87-EV human glioblastoma xenograft - Control 52.2868913
GSM967862U87-EV human glioblastoma xenograft - Bevacizumab treated 12.4846618
GSM967863U87-EV human glioblastoma xenograft - Bevacizumab treated 22.3077811
GSM967864U87-EV human glioblastoma xenograft - Bevacizumab treated 32.2496511
GSM967865U87-EV human glioblastoma xenograft - Bevacizumab treated 42.2663112
GSM967857U87-EV human glioblastoma xenograft - dibenzazepine treated 12.3026313
GSM967858U87-EV human glioblastoma xenograft - dibenzazepine treated 22.2764212
GSM967859U87-EV human glioblastoma xenograft - dibenzazepine treated 32.2663912
GSM967860U87-EV human glioblastoma xenograft - dibenzazepine treated 42.2645111
GSM967861U87-EV human glioblastoma xenograft - dibenzazepine treated 52.283912